Melvin Reichman

1.0k total citations
28 papers, 852 citations indexed

About

Melvin Reichman is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Pharmacology. According to data from OpenAlex, Melvin Reichman has authored 28 papers receiving a total of 852 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 8 papers in Cellular and Molecular Neuroscience and 4 papers in Pharmacology. Recurrent topics in Melvin Reichman's work include Neuroscience and Neuropharmacology Research (6 papers), Pharmacological Receptor Mechanisms and Effects (3 papers) and Receptor Mechanisms and Signaling (3 papers). Melvin Reichman is often cited by papers focused on Neuroscience and Neuropharmacology Research (6 papers), Pharmacological Receptor Mechanisms and Effects (3 papers) and Receptor Mechanisms and Signaling (3 papers). Melvin Reichman collaborates with scholars based in United States, China and United Kingdom. Melvin Reichman's co-authors include Awilda Stapelfeld, Michael A. Savage, E. Ann Hallinan, L E Hokin, D. Schultz, Peter B. Simpson, Preston S. Donover, Lowell E. Hokin, Glenn Croston and Michael R. Briggs and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and Blood.

In The Last Decade

Melvin Reichman

27 papers receiving 814 citations

Peers

Countries citing papers authored by Melvin Reichman

Since Specialization

Citations

This map shows the geographic impact of Melvin Reichman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Melvin Reichman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Melvin Reichman more than expected).

Fields of papers citing papers by Melvin Reichman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Melvin Reichman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Melvin Reichman. The network helps show where Melvin Reichman may publish in the future.

Co-authorship network of co-authors of Melvin Reichman

This figure shows the co-authorship network connecting the top 25 collaborators of Melvin Reichman. A scholar is included among the top collaborators of Melvin Reichman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Melvin Reichman. Melvin Reichman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Preclinical study of the long‐range safety and anti‐inflammatory effects of high‐dose oral meglumine 2019 ·Journal of Cellular Biochemistry ·(unknown), Arturo Bravo‐Nuevo, (unknown), (unknown), (unknown), Melvin Reichman, (unknown), Carol M. Artlett, Susan K. Gilmour, Lisa D. Laury‐Kleintop, George C. Prendergast	6
2	Development and Validation of a Universal High-Throughput UDP-Glycosyltransferase Assay with a Time-Resolved FRET Signal 2016 ·Assay and Drug Development Technologies ·(unknown), Melvin Reichman, Preston S. Donover, Robert G. Lowery	16
3	Open innovation in early drug discovery: roadmaps and roadblocks 2015 ·Drug Discovery Today ·Melvin Reichman, Peter B. Simpson	22
4	A High-Throughput Assay for Rho Guanine Nucleotide Exchange Factors Based on the Transcreener GDP Assay 2015 ·SLAS DISCOVERY ·Melvin Reichman, (unknown), (unknown), (unknown), Preston S. Donover, Lisa D. Laury‐Kleintop, Robert G. Lowery	6
5	Meglumine Exerts Protective Effects against Features of Metabolic Syndrome and Type II Diabetes 2014 ·PLoS ONE ·Arturo Bravo‐Nuevo, (unknown), Minzhou Huang, (unknown), (unknown), Lisa D. Laury‐Kleintop, Melvin Reichman, (unknown), George C. Prendergast	8
6	Opening the lead generation toolbox 2013 ·Nature Reviews Drug Discovery ·Peter B. Simpson, Melvin Reichman	13
7	New Informatics and Automated Infrastructure to Accelerate New Leads Discovery by High Throughput Screening (HTS) 2013 ·Combinatorial Chemistry & High Throughput Screening ·Preston S. Donover, (unknown), (unknown), Andrew Wright, (unknown), (unknown), (unknown), Melvin Reichman	6
8	Identification and Characterization of Small Molecule Antagonists of pRb Inactivation by Viral Oncoproteins 2012 ·Chemistry & Biology ·Daniela Fera, D. Schultz, Santosh Hodawadekar, Melvin Reichman, Preston S. Donover, (unknown), Scott Troutman, Joseph L. Kissil, Donna M. Huryn, Ronen Marmorstein	26
9	Development of a High-Throughput Screen for Inhibitors of Epstein-Barr Virus EBNA1 2010 ·SLAS DISCOVERY ·(unknown), Troy E. Messick, D. Schultz, Melvin Reichman, Paul M. Lieberman	42
10	Novel nonsecosteroidal vitamin D mimics exert VDR-modulating activities with less calcium mobilization than 1,25-dihydroxyvitamin D3 1999 ·Chemistry & Biology ·Marcus F. Boehm, Patrick Fitzgerald, Aihua Zou, Marc Elgort, Eric D. Bischoff, (unknown), Dale E. Mais, Reid P. Bissonnette, R A Heyman, Alex M. Nadzan, Melvin Reichman, Elizabeth A. Allegretto	120
11	8-chlorodibenz[b,f][1,4]oxazepine-10(11H)-carboxylic acid,2-[3-[2-(furanylmethyl)thio]-1-oxopropyl]hydrazide (SC-51322): A potent PGE2 antagonist and analgesic 1994 ·Bioorganic & Medicinal Chemistry Letters ·E. Ann Hallinan, Awilda Stapelfeld, Michael A. Savage, Melvin Reichman	63
12	N-Substituted dibenzoxazepines as analgesic PGE2 antagonists 1993 ·Journal of Medicinal Chemistry ·E. Ann Hallinan, Timothy J. Hagen, (unknown), (unknown), (unknown), (unknown), Michael Rafferty, Awilda Stapelfeld, Michael A. Savage, Melvin Reichman	63
13	Systemic analgesic activity and .delta.-opioid selectivity in [2,6-dimethyl-Tyr1, D-Pen2, D-Pen5]enkephalin 1992 ·Journal of Medicinal Chemistry ·(unknown), Awilda Stapelfeld, Michael A. Savage, Melvin Reichman, Donna L. Hammond, Ronald C. Haaseth, Henry I. Mosberg	83
14	Analogs of the .delta. opioid receptor selective cyclic peptide [cyclic][2-D-penicillamine,5-D-penicillamine]-enkephalin: 2',6'-dimethyltyrosine and Gly3-Phe4 amide bond isostere substitutions 1992 ·Journal of Medicinal Chemistry ·Nizal S. Chandrakumar, Awilda Stapelfeld, Patrick M. Beardsley, (unknown), (unknown), Elizabeth Y. Anthony, Michael A. Savage, (unknown), Melvin Reichman	31
15	Li+ increases accumulation of inositol 1,4,5-trisphosphate and inositol 1,3,4,5-tetrakisphosphate in cholinergically stimulated brain cortex slices in guinea pig, mouse and rat. The increases require inositol supplementation in mouse and rat but not in guinea pig 1992 ·Biochemical Journal ·(unknown), J F Dixon, Melvin Reichman, Chafiq Moummi, Georgyi V. Los, L E Hokin	51
16	Delta 9-tetrahydrocannabinol increases arachidonic acid levels in guinea pig cerebral cortex slices. 1988 ·Molecular Pharmacology ·Melvin Reichman, (unknown), L E Hokin	31
17	Cerebral microvascular and parenchymal phospholipid composition in the mouse 1988 ·Neurochemical Research ·Wesley M. Williams, Melvin Reichman, Thomas H. McNeill	11
18	Biochemical aspects of the phosphoinositide signalling system with special reference to the formation of inositol cyclic phosphates and arachidonic acid and metabolites on agonist stimulation 1987 ·PubMed ·Lowell E. Hokin, John F. Dixon, Melvin Reichman, Mahendran Sekar	4
19	Effects of delta 9-tetrahydrocannabinol on prostaglandin formation in brain. 1987 ·Molecular Pharmacology ·Melvin Reichman, (unknown), L E Hokin	8
20	Beneficial effects of high-dose diltiazem in patients with persistent effort angina on beta-blockers and nitrates: a randomized, double-blind, placebo-controlled cross-over study. 1985 ·Circulation ·William E. Boden, Edward W. Bough, Melvin Reichman, (unknown), Phillip M. Young, Kenneth S. Korr, R S Shulman	47

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact